FABA holding 21-day virtual workshop on drug discovery

Hyderabad: Federation of Asian Biotech Associations (FABA) on Sunday said it is organising Drug Discovery and Development (DDD), a virtual workshop, for the fourth time in collaboration with the Science Gurus, a US-based nonprofit organisation, and the University of Hyderabad, for 21 days from March 13 to April 2, 2023. This workshop is supported by Biotechnology Industry Research Assistance Council (BIRAC), World Trade Center Shamshabad & Visakhapatnam, Suven Pharma and Hetero Pharma.

Prof E Premkumar Reddy, Director, Icahn School of Medicine at Mount Sinai, New York, is chief guest for the workshop in which prominent speakers from India, the US and Europe will participate and speak on breakthrough advances in the field of drug discovery and development during each session of the workshop. Dr Radha Rangarajan, Director, CSIR-CDRI, will be the chief guest for valedictory session.

Prof P Reddanna, Executive President, FABA said, “The workshop will be emphasizing on the topics of Discovery: target identification, and validation, including molecular modeling and drug design; Pre-clinical Development: focusing drug metabolism, PK and PD studies; Development: drug manufacturing, process development, and formulation; Clinical Development: phase I to IV studies, including Regulatory Affairs; The Next Frontier: emerging technologies like Artificial Intelligence, Data sciences, personalised medicine, and drug repurposing.”

FABA, as part of FABA Academy’s continuing education programme, is delighted to bring this wide-ranging workshop filled with enriching content to provide an opportunity for the participants to learn different aspects of the drug discovery and development process, Prof P Reddanna said.

The participants will also have the opportunity to learn from the experience of the success stories of biotech and pharma startups.

The workshop’s participants include undergraduate students, postgraduates, research and postdoctoral scholars, and research scientists from universities, research institutions, and pharma/biotech industries across India, Bangladesh, Israel, Nigeria, Sri Lanka and Iran. They will have opportunities to present and discuss case studies and interact with the experts. The workshop also includes an interactive panel discussion which will be moderated by Dr Uday Saxena, EC Member, FABA, where eminent industry experts will speak on the "Future of drug discovery in India". The session will give a clear and comprehensive overview of the development and production of various molecular and immune diagnostics.